Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Eledon Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- +13 vs. Q3 2025
- Shares held
- 44.2M
- +7.74M (+21.3%) vs. Q3 2025
- Total value
- $66.7M
- −$27.6M (−29.3%) vs. Q3 2025
- New holders
- 32
- 32 more added
- Sold out
- 19
- 17 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kovitz Investment Group Partners, LLC | 0 | $0 | 0.00% | −732,975−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −346,973−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −64,110−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −39,355−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −36,297−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −21,572−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −19,072−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −18,628−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −15,997−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,217−100.0% | Sold out |
| Redwood Park Advisors LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Wolverine Trading, LLC | – | – | – | – | Not filed |